Literature DB >> 20847820

Implementation and Benefits of Psychooncological Group Interventions in German Breast Centers: A Pilot Study on Supportive-Expressive Group Therapy for Women with Primary Breast Cancer.

Katrin Reuter1, Isabelle Scholl, Martin Sillem, Annette Hasenburg, Martin Härter.   

Abstract

BACKGROUND: Psychosocial treatment is an integral component in today's comprehensive breast cancer care. The main goal of this study was to test the feasibility (benefits and acceptance) of supportive-expressive group psychotherapy (SEGT), a short-term breast cancer-specific group therapy developed and tested in Anglo-American countries, within breast centers in Germany. PATIENTS AND METHODS: The study was realized as a single-group pre-post design. Data were analyzed by combining quantitative and qualitative research methods. The sample consisted of 49 women with breast cancer stage 1 or 2 according to TNM classification (tumor, node, metastasis).
RESULTS: The results indicate positive acceptance of the group intervention. Quality of life, tumor-related fatigue and coping strategies improved after SEGT. 1 year after the intervention, the patients report lasting positive results from the group intervention.
CONCLUSIONS: This pilot study illustrates the importance of psychooncological group interventions for breast cancer patients and indicates that this form of outpatient psychooncological care is feasible within the German health care system, and breast centers in particular. Effectiveness has to be investigated in randomized controlled trials.

Entities:  

Year:  2010        PMID: 20847820      PMCID: PMC2931042          DOI: 10.1159/000297739

Source DB:  PubMed          Journal:  Breast Care (Basel)        ISSN: 1661-3791            Impact factor:   2.860


  15 in total

1.  Breast Centers in Germany.

Authors:  Ute-Susann Albert; Uwe Wagner; Matthias Kalder
Journal:  Breast Care (Basel)       Date:  2009-08-14       Impact factor: 2.860

2.  World Medical Association declaration of Helsinki. Recommendations guiding physicians in biomedical research involving human subjects.

Authors: 
Journal:  JAMA       Date:  1997-03-19       Impact factor: 56.272

3.  The European Organization for Research and Treatment of Cancer breast cancer-specific quality-of-life questionnaire module: first results from a three-country field study.

Authors:  M A Sprangers; M Groenvold; J I Arraras; J Franklin; A te Velde; M Muller; L Franzini; A Williams; H C de Haes; P Hopwood; A Cull; N K Aaronson
Journal:  J Clin Oncol       Date:  1996-10       Impact factor: 44.544

4.  Screening new cancer patients for psychological distress using the hospital anxiety and depression scale.

Authors:  Scott M Sellick; Alan D Edwardson
Journal:  Psychooncology       Date:  2007-06       Impact factor: 3.894

5.  Group psychotherapy for recently diagnosed breast cancer patients: a multicenter feasibility study.

Authors:  D Spiegel; G R Morrow; C Classen; R Raubertas; P B Stott; N Mudaliar; H I Pierce; P J Flynn; L Heard; G Riggs
Journal:  Psychooncology       Date:  1999 Nov-Dec       Impact factor: 3.894

6.  Supportive-expressive group therapy and distress in patients with metastatic breast cancer: a randomized clinical intervention trial.

Authors:  C Classen; L D Butler; C Koopman; E Miller; S DiMiceli; J Giese-Davis; P Fobair; R W Carlson; H C Kraemer; D Spiegel
Journal:  Arch Gen Psychiatry       Date:  2001-05

7.  The European Organization for Research and Treatment of Cancer QLQ-C30: a quality-of-life instrument for use in international clinical trials in oncology.

Authors:  N K Aaronson; S Ahmedzai; B Bergman; M Bullinger; A Cull; N J Duez; A Filiberti; H Flechtner; S B Fleishman; J C de Haes
Journal:  J Natl Cancer Inst       Date:  1993-03-03       Impact factor: 13.506

8.  Cognitive-existential group psychotherapy for women with primary breast cancer: a randomised controlled trial.

Authors:  David W Kissane; Sidney Bloch; Graeme C Smith; Patricia Miach; David M Clarke; Jillian Ikin; Anthony Love; Nadia Ranieri; Dean McKenzie
Journal:  Psychooncology       Date:  2003-09       Impact factor: 3.894

9.  Supportive-expressive group therapy for primary breast cancer patients: a randomized prospective multicenter trial.

Authors:  Catherine C Classen; Helena C Kraemer; Christine Blasey; Janine Giese-Davis; Cheryl Koopman; Oxana Gronskaya Palesh; Ami Atkinson; Sue Dimiceli; Gail Stonisch-Riggs; Joan Westendorp; Gary R Morrow; David Spiegel
Journal:  Psychooncology       Date:  2008-05       Impact factor: 3.894

10.  Group support for patients with metastatic cancer. A randomized outcome study.

Authors:  D Spiegel; J R Bloom; I Yalom
Journal:  Arch Gen Psychiatry       Date:  1981-05
View more
  3 in total

1.  Brief supportive-expressive group therapy for partners of men with early stage prostate cancer: lessons learned from a negative randomized controlled trial.

Authors:  Linda E Carlson; Codie R Rouleau; Michael Speca; John Robinson; Barry D Bultz
Journal:  Support Care Cancer       Date:  2017-01-07       Impact factor: 3.603

2.  Targeting the Psychosexual Challenges Faced by Couples with Breast Cancer: Can Couples Group Psychotherapy Help?

Authors:  Luciana Lagana; Patricia Fobair; David Spiegel
Journal:  J Womens Health Care       Date:  2014-11-17

3.  Randomized controlled trial of supportive-expressive group therapy and body-mind-spirit intervention for Chinese non-metastatic breast cancer patients.

Authors:  Rainbow T H Ho; Ted C T Fong; Phyllis H Y Lo; Samuel M Y Ho; Peter W H Lee; Pamela P Y Leung; David Spiegel; Cecilia L W Chan
Journal:  Support Care Cancer       Date:  2016-07-28       Impact factor: 3.603

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.